Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040323 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2SLC22A6KMT2AMAPTGABRR1 | |
| SCHEMBL222024 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2SLC22A6KMT2AMAPTGABRR1 | |
| Ammonia Solution, Strong SCHEMBL21219123 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2SLC22A6KMT2AMAPTGABRR1 | |
| SCHEMBL10933476 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2SLC22A6KMT2AMAPTGABRR1 | |
| Ethylene SCHEMBL5860683 | 0.95 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6KMT2AMAPTGABRR1 | |
| Acrylamide SCHEMBL28172860 | 0.84 | TSHR (0.39) | SMN1; SMN2SLC22A6KMT2AGABRR1LMNA | |
| SCHEMBL8627026 | 0.84 | SMN1; SMN2 (0.36) | SMN1; SMN2SLC22A6KMT2AMAPTTSHR | |
| SCHEMBL1691025 | 0.80 | TSHR (0.43) | SMN1; SMN2KMT2AMAPTTSHRCA1 | |
| SCHEMBL8060426 | 0.80 | ALDH1A1 (0.42) | SMN1; SMN2KMT2ALMNATDP1TSHR | |
| SCHEMBL1823637 | 0.80 | TSHR (0.43) | SMN1; SMN2KMT2AMAPTTSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119638965-B | Polyester microparticles, process for producing the same, and injection-filled article | 广东粤港澳大湾区黄埔材料研究院 | 2025-05-13 | — | — | CN | claimed |
| CN-119799159-A | Bio-based UV curing release agent, preparation method thereof and release film | 江苏斯迪克新材料科技股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119638965-A | Polyester microparticles, process for producing the same, and injection-filled article | 广东粤港澳大湾区黄埔材料研究院 | 2025-03-18 | — | — | CN | claimed |
| CN-118853722-B | Method for improving yield of synthesized L-isoleucine based on methyl malic acid pathway and engineering strain | 中国农业科学院北京畜牧兽医研究所 | 2024-12-06 | — | — | CN | claimed |
| CN-118638831-B | Coli engineering strain with phage resistance for producing methyl malic acid, construction and fermentation production method | 中国农业科学院北京畜牧兽医研究所 | 2024-10-29 | — | — | CN | claimed |
| CN-118853722-A | Method for improving yield of synthesized L-isoleucine based on methyl malic acid pathway and engineering strain | 中国农业科学院北京畜牧兽医研究所 | 2024-10-29 | — | — | CN | claimed |
| CN-118638831-A | Coli engineering strain with phage resistance for producing methyl malic acid, construction and fermentation production method | 中国农业科学院北京畜牧兽医研究所 | 2024-09-13 | — | — | CN | claimed |
| CN-118530442-A | Polyester microparticle, preparation method thereof and soluble microneedle patch containing polyester microparticle | 广东粤港澳大湾区黄埔材料研究院 | 2024-08-23 | — | — | CN | claimed |
| CN-117683802-B | Ralstonia engineering strain for producing isoleucine through methyl malic acid pathway, construction method and production method thereof | 中国农业科学院北京畜牧兽医研究所 | 2024-07-05 | — | — | CN | claimed |
| WO-2023081515-A1 | BIODEGRADABLE SUSTAINABLE POLYESTERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-11 | — | — | WO | claimed |
| US-11229621-B2 | Pharmaceutical compositions of dimethyl fumarate | ARBOR PHARMACEUTICALS, LLC (US) | 2022-01-25 | — | — | US | claimed |
| WO-2021136977-A1 | A PROCESS FOR PRODUCING TRIMELLITIC ACID FROM BIOMASS | INDIAN INSTITUTE OF TECHNOLOGY, DELHI (IN) | 2021-07-08 | — | — | WO | claimed |
| WO-2021019555-A1 | A PROCESS FOR THE PREPARATION OF 4-AMINO-2-HYDROXY-4-OXOBUTANOIC ACID AND PRODUCT PREPARED THEREFROM | INDIAN COUNCIL OF MEDICAL RESEARCH (IN) | 2021-02-04 | — | — | WO | claimed |
| US-20200155496-A1 | Pharmaceutical Compositions of Dimethyl Fumarate | HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT | 2020-05-21 | — | — | US | claimed |
| US-20150056215-A1 | METHODS OF TREATING PROLIFERATIVE DISORDERS WITH MALATE OR DERIVATIVES THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2015-02-26 | — | — | US | claimed |
| WO-2014160633-A1 | PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE | XENOPORT, INC. (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140284245-A1 | PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE | XENOPORT, INC. (US) | 2014-09-25 | — | — | US | claimed |
| CN-102276689-A | Chemical synthesis method of histone deacetylase inhibitor FK228 and application thereof | — | 2011-12-14 | — | — | CN | claimed |
| US-20070190187-A1 | FORMULATION FOR ENHANCED DELIVERY OF PHENETHYLAMINE | KNELLER BRUCE W | 2007-08-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190187-A1 | FORMULATION FOR ENHANCED DELIVERY OF PHENETHYLAMINE | MAOB, PNMT, MAOA | SMN1; SMN2 1565/4885SLC22A6 855/4885KMT2A 96/4885 |
| US-11229621-B2 | Pharmaceutical compositions of dimethyl fumarate | FH, SDHB, SDHA | SMN1; SMN2 2659/4885SLC22A6 886/4885KMT2A 1144/4885 |
| US-20200155496-A1 | Pharmaceutical Compositions of Dimethyl Fumarate | FH, SDHB, SDHA | SMN1; SMN2 2659/4885SLC22A6 886/4885KMT2A 1144/4885 |
| US-20150056215-A1 | METHODS OF TREATING PROLIFERATIVE DISORDERS WITH MALATE OR DERIVATIVES THEREOF | MDH2, MDH1, ME1 | SMN1; SMN2 3163/4885SLC22A6 298/4885KMT2A 1013/4885 |
| US-20140284245-A1 | PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE | FH, SDHB, SDHA | SMN1; SMN2 2659/4885SLC22A6 886/4885KMT2A 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.